Uprichard had been president and head of research and development at the Lexington, MA-based MR contrast developer since 2006. He will continue to assist Epix as a consultant, according to the company.
Related Reading
Epix to resubmit NDA for Vasovist, April 24, 2008
Epix reaches agreement with FDA over Vasovist, February 1, 2008
Epix to raise $16.3 million, November 12, 2007
Epix receives FDA response, June 19, 2007
Epix posts big Q1 loss, May 9, 2007
Copyright © 2008 AuntMinnie.com
